Finance

Lists
Why is MPARK up 2.98%?
Dive Deeper
MPARK:IST
MLP Saglik Hizmetleri AS
TRY 466.00
+2.98%
(+13.50) 1D
Nov 13, 6:10:00 PM GMT+3  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for MPARK...
Open
TRY 452.00
High
TRY 467.75
Low
TRY 448.75
Mkt. cap
89.01B
Avg. vol.
521.50K
Volume
0.00
P/E ratio
13.24
52-wk high
TRY 514.00
52-wk low
TRY 304.00
EPS
TRY 35.20
Shares outstanding
191.01M
No. of employees
15K
Open
TRY 452.00
High
TRY 467.75
Low
TRY 448.75
Mkt. cap
89.01B
Avg. vol.
521.50K
Volume
0.00
P/E ratio
13.24
52-wk high
TRY 514.00
52-wk low
TRY 304.00
EPS
TRY 35.20
Shares outstanding
191.01M
No. of employees
15K
News stories
From web sources and news partners
Profile
Medical Park Hospitals Group, which has been active in the health care sector since 1995, offers service in various provinces of Turkey with more than 6,000 doctors and employees, 17 hospitals in total. Medical Park is the biggest hospital group in Turkey. The hospital chain was founded by Muharrem Usta, who currently chairs the company. The company owned two hospitals in Istanbul in 2005. In 2006, he initially sold 30% of the company shares to Sancak family. This partnership enabled a rapid growth of the company that led to the establishment of 13 hospitals with 2,000 beds within three years. By the end of 2009, 40% of the company shares were sold to the third biggest US-American global asset management firm The Carlyle Group. With this new partnership, the number of hospitals reached 17 with 2,771 beds in total that placed the company on first rank of its kind in Turkey. In March 2013, it was reported that the Carlyle Group sold its shares at Medical Park to the largest US-American private equity investment firm Texas Pacific Group. Wikipedia
About MLP Saglik Hizmetleri AS
CEOMuharrem Usta
Employees15.4K
Founded1993
Headquarters-
SectorHealth Care
IndustryHealth care provider
Website-
Previous reportsAll values in TRY
Loading Previous Earnings...
Revenue
Net income
All values in TRY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
15.87B
17.39B
18.64B
18.19B
Cost of goods sold
11.33B
12.61B
14.00B
13.08B
Cost of revenue
11.33B
12.61B
14.00B
13.08B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.32B
1.49B
1.54B
1.50B
Operating expense
1.54B
2.05B
1.96B
1.95B
Total operating expenses
12.87B
14.66B
15.96B
15.03B
Operating income
3.00B
2.73B
2.68B
3.16B
Other non operating income
333.68M
816.86M
937.02M
691.20M
EBT including unusual items
3.24B
2.31B
2.20B
2.75B
EBT excluding unusual items
3.26B
2.38B
2.38B
2.76B
Income tax expense
1.56B
317.86M
448.81M
679.58M
Effective tax rate
48.19%
13.76%
20.43%
24.68%
Other operating expenses
213.73M
557.76M
413.46M
445.33M
Net income
1.46B
1.78B
1.54B
2.22B
Net profit margin
9.21%
10.26%
8.28%
12.23%
Earnings per share
-
-
-
-
Interest and investment income
1.68B
665.18M
745.49M
806.61M
Interest expense
-1.75B
-1.81B
-2.14B
-2.07B
Net interest expenses
-67.71M
-1.15B
-1.40B
-1.26B
Depreciation and amortization charges
-
-
-
-
EBITDA
3.94B
3.72B
3.66B
4.26B
Gain or loss from assets sale
-1.33B
-6.29M
155.54M
383.00K
Upcoming events
AI content may include mistakes. Learn more
Google apps